Symbols

PPBT

Purple Biotech·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 2

Consensus Rating "Strong Buy"

Significant Net Income Decline

Dark Cloud Cover

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About PPBT

Purple Biotech Ltd.

A biotech company that develops and commercializes novel therapies for cancer and other diseases

Industry

Pharmaceutical

Established Date

08/12/1968

Listing Date

11/20/2015

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.purple-biotech.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

4 Oppenheimer Street Science Park Rehovot 7670104 Israel

Business

Bio-pharmacy.

Introduction

Purple Biotech Ltd., was incorporated under the laws of the State of Israel on August 12, 1968. The company is a clinical-stage company developing next-generation immunotherapy platforms designed to maximize anticancer efficacy while minimizing toxicity.

Company Financials

EPS

PPBT has released its 2025 Q4 earnings. EPS was reported at -19.85, versus the expected -3.4, missing expectations. The chart below visualizes how PPBT has performed over recent quarters, highlighting trends in earnings surprises.